Actavis Infringed Constipation Drug Patent, Judge Rules
A New Jersey federal judge has upheld a patent covering Bausch Health Cos.' opioid-induced constipation drug Relistor and ruled Actavis Laboratories' planned generic version infringes the patent....To view the full article, register now.
Already a subscriber? Click here to view full article